OverviewChartNewsTraderScreen

Zai Lab Limited/  US98887Q1040  /

IEX
2024-04-24  9:59:59 PM Chg. +0.53 Volume Bid- Ask- High Low
15.66USD +3.50% 17,624
Turnover: 277,436.46		 -Bid Size: - -Ask Size: - 16.07 15.49
GlobeNewswire 04-18 Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and Investigator-Initiated P...
GlobeNewswire 01-04 Former Biogen CEO Michel Vounatsos Joins Quris-AI Board
GlobeNewswire 2023-12-13 Paratek Pharmaceuticals Announces Inclusion of Oral NUZYRA® in China’s National Reimbursement Drug L...
GlobeNewswire 2023-11-07 Zai Lab Announces Third Quarter 2023 Financial Results and Recent Corporate Updates
GlobeNewswire 2023-10-26 Zai Lab Announces Participation in November Investor Conferences
GlobeNewswire 2023-10-18 Zai Lab to Announce Third Quarter 2023 Financial Results and Recent Corporate Updates on November 7,...
GlobeNewswire 2023-09-18 Zai Lab Obtains Breakthrough Therapy Designation for Efgartigimod Alfa Injection (Subcutaneous Injec...
GlobeNewswire 2023-09-04 Genmab and Seagen Announce That TIVDAK® (tisotumab vedotin-tftv) Met its Primary Endpoint of Improve...
GlobeNewswire 2023-08-30 Zai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib for Treatment of Patien...
GlobeNewswire 2023-08-29 Zai Lab Announces Participation in September Investor Conferences
GlobeNewswire 2022-03-23 Zai Lab Announces Change to Virtual Extraordinary General Meeting of Shareholders to be Held on Marc...
GlobeNewswire 2022-03-22 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zai Lab Limited ...
GlobeNewswire 2022-03-21 Zai Lab Presents Positive Results from Phase 3 PRIME Study of ZEJULA® (Niraparib) at Society of Gyne...
GlobeNewswire 2022-03-16 (ZLAB) Alert: Did you Suffer a Substantial Loss? Contact Johnson Fistel About Leading ZLAB Class Act...
GlobeNewswire 2022-03-15 Zai Lab Announces the Appointment of Josh Smiley as Chief Operating Officer
GlobeNewswire 2022-03-14 Paratek Pharmaceuticals Announces Full-Year 2021 Revenue of $130.2 Million
GlobeNewswire 2022-03-01 Zai Lab Announces Financial Results and Corporate Updates for Twelve Months Ended December 31, 2021
GlobeNewswire 2022-02-17 Zai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib in China
GlobeNewswire 2022-02-15 Zai Lab to Announce Full-Year Financial Results and Corporate Updates on March 1, 2022
GlobeNewswire 2022-02-07 Zai Lab Announces Upcoming Presentation at February Investor Conference
GlobeNewswire 2022-01-12 Zai Lab Announces First Patient Treated in Greater China in PANOVA-3 Phase 3 Pivotal Trial of Tumor ...
GlobeNewswire 2021-12-29 Zai Lab Announces Upcoming Presentations at January Investor Conferences
GlobeNewswire 2021-12-22 Zai Lab Announces Promotion of Harald Reinhart, M.D. to President and Head of Global Development, Ne...
GlobeNewswire 2021-12-18 Zai Lab Partner argenx Announces U.S. Food and Drug Administration (FDA) Approval of VYVGART™ (efgar...
GlobeNewswire 2021-12-16 China's National Medical Products Administration Approves NUZYRA® (omadacycline) for the Treatment o...